1. Home
  2. CGBD vs ORIC Comparison

CGBD vs ORIC Comparison

Compare CGBD & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Carlyle Secured Lending Inc.

CGBD

Carlyle Secured Lending Inc.

HOLD

Current Price

$10.69

Market Cap

826.2M

Sector

Finance

ML Signal

HOLD

Logo Oric Pharmaceuticals Inc.

ORIC

Oric Pharmaceuticals Inc.

HOLD

Current Price

$8.31

Market Cap

861.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CGBD
ORIC
Founded
2012
2014
Country
United States
United States
Employees
2500
104
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
826.2M
861.3M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
CGBD
ORIC
Price
$10.69
$8.31
Analyst Decision
Hold
Strong Buy
Analyst Count
8
13
Target Price
$12.92
$19.73
AVG Volume (30 Days)
570.6K
1.2M
Earning Date
05-11-2026
05-05-2026
Dividend Yield
14.42%
N/A
EPS Growth
N/A
19.67
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$3.74
N/A
Revenue Next Year
$1.80
N/A
P/E Ratio
$10.36
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.64
$5.51
52 Week High
$14.32
$14.93

Technical Indicators

Market Signals
Indicator
CGBD
ORIC
Relative Strength Index (RSI) 33.31 37.06
Support Level $10.68 $7.90
Resistance Level $12.17 $11.22
Average True Range (ATR) 0.30 0.44
MACD -0.10 -0.01
Stochastic Oscillator 3.80 30.75

Price Performance

Historical Comparison
CGBD
ORIC

About CGBD Carlyle Secured Lending Inc.

Carlyle Secured Lending Inc is a specialty finance company that is a closed-end, externally managed, non-diversified management investment company. It focuses on providing directly originated, financing solutions across the capital structure, with a focus on senior secured lending to middle-market companies located in the United States. The company's investment objective is to generate current income and capital appreciation through debt investments in U.S. middle-market companies.

About ORIC Oric Pharmaceuticals Inc.

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.

Share on Social Networks: